The light-blue cluster, featuring keywords including “radiation,” “tumor growth,” “resistance,” “reactive oxygen,” “kappa-b,” and “signal transducer and activator of transcription 3,” addresses glioma responses to radiotherapy, chemotherapy, and agents like temozolomide within oxidative stress contexts, exploring tumor growth dynamics and resistance mechanisms mediated by these factors. Here, STAT3 is linked to glioma.